KING OF PRUSSIA, PA — CSL Behring, the biotechnology unit of CSL Limited, recently unveiled a 10g prefilled syringe for Hizentra, its treatment for Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This development aims to simplify the treatment process for patients by eliminating the need to draw medication from vials.
Hizentra is an under-the-skin infusion therapy that allows patients with PI or CIDP to self-administer their treatment at home. This can be particularly beneficial for individuals who may have venous access issues or for those who wish to avoid frequent trips to an infusion center.
The launch of the 10g prefilled syringe is part of CSL Behring’s ongoing efforts to cater to the diverse needs of patients with rare diseases. The company already offers Hizentra in a variety of prefilled syringe sizes, including 1g, 2g, and 4g options.
Bob Lojewski, Senior Vice President and General Manager, North America, CSL Behring, described the introduction of the 10g prefilled syringe as a significant milestone. “This latest development helps the rare disease community effectively manage PI and CIDP, especially as some patients may require treatment at a higher volume,” he said.
The decision to offer a larger-volume option comes as more patients seek convenient treatment alternatives. According to a Harris Poll survey, around 72% of 100 adults living with CIDP felt that self-administering treatment at home was extremely important. Similarly, nearly 80% of 52 PI patients who had used both subcutaneous immunoglobulin (SCIg) and intravenous immunoglobulin (IVIg) treatments expressed a preference for SCIg.
CSL Behring’s commitment to addressing the needs of patients with rare diseases is evident in its continuous efforts to enhance treatment accessibility and convenience. The introduction of the 10g prefilled syringe for Hizentra is yet another stride in the company’s endeavor to improve the quality of life for individuals living with PI and CIDP.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.